Patents Assigned to Curators of the University
  • Patent number: 9901617
    Abstract: Here, we identify Plenty of SH3 (POSH) and JNK-interacting protein 1 (JIP-1) as a multi-protein scaffold network for TCR-mediated JNK1 activation in CD8+ T-cells. Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet and Eomesodermin. Furthermore, disruption of the POSH/JIP complex in CD8+ T-cells resulted in impaired proliferation, decreased cytokine expression and the inability to control tumors. Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8+ T-cell responses. A group of compounds are described that individually or in concert target a common set of biological pathways important in T cell function, activation of innate inflammation, ischemic reperfusion injury, HIV release and oncogenesis.
    Type: Grant
    Filed: August 14, 2014
    Date of Patent: February 27, 2018
    Assignee: The Curators of the University of Missouri
    Inventor: Mark A. Daniels
  • Patent number: 9898016
    Abstract: Methods and products are provided for facilitating application of variable-product agrochemicals, such as fertilizer, to an application area, such as a field. The fertilizer or agrochemical may include a single fertilizer or agrochemical type or a mixture. In one embodiment, a fertilizer-application area is divided into application cells, and a fertilizer product is determined for each cell, based on zones of the application area with a similar characteristic, such as topographic wetness index levels. Based on a determined product for each cell, instructions for controlling an agrochemical applicator are automatically generated.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: February 20, 2018
    Assignee: The Curators of the University of Missouri
    Inventors: Peter P. Motavalli, Kelly A. Nelson
  • Publication number: 20180047570
    Abstract: The present invention provides a method to manufacture nanowires. In various embodiments, a method is provided for producing an oxidized metal layer as a heterogeneous seed layer on arbitrary substrate for controlled nanowire growth is disclosed which comprises depositing a metal layer on a substrate, oxidizing the metal layer in air ambient or in oxidizing agent, and growing nanowires at low temperatures on oxidized metal layers on virtually any substrate.
    Type: Application
    Filed: October 11, 2017
    Publication date: February 15, 2018
    Applicant: The Curators of the University of Missouri
    Inventors: Jae Wan Kwon, Baek Hyun Kim
  • Patent number: 9885040
    Abstract: The invention provides methods and compositions for treatment of spinal muscular atrophy (SMA). In one aspect of the invention, a series of compositions comprising an antisense oligonucleotide targeting the Element 1 site on the SMN2 pre-mRNA and a Morpholino backbone is disclosed. In another aspect of the invention, a method of treating SMA patients by modulating the splicing of SMN2 pre-mRNA to increase the amount of full-length SMN is disclosed. Certain embodiments of the inventive method comprise administering an E1-targeting antisense oligonucleotide, such as Morpholino based antisense oligonucleotide, to a SMA subject.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: February 6, 2018
    Assignee: The Curators of The University Of Missouri
    Inventors: Christian Lorson, Erkan Osman
  • Patent number: 9883576
    Abstract: A low-power, compact piezoelectric particle emitter for emitting particles such as X-rays and neutrons. A piezoelectric transformer crystal receives an input voltage at an input end and generates a higher output voltage at an output electrode disposed at an output end. The emitter is in a vacuum and the output voltage creates an electric field. A charged particle source is positioned relative a target such that charged particles from the charged particle source are accelerated by the electric field toward the target. Interaction between the accelerated charged particles and the target causes one of X-rays and neutrons to be emitted.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: January 30, 2018
    Assignee: The Curators of the University of Missouri
    Inventors: Scott D. Kovaleski, Brady B. Gall, Andrew L. Benwell, Peter Norgard, James Vangordon
  • Patent number: 9872647
    Abstract: Systems and methods are described herein for determining that a patient has indications mild cognitive impairment (MCI) or early stage Alzheimer's disease (AD). Microperimetry is used to assess the functional integrity of the patient's retina. Optical Coherence Tomography is used to assess the structural integrity of the patient's retina. Reductions in the size and function of the patient's retina indicate that the patient may have MCI or early stage AD.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: January 23, 2018
    Assignee: The Curators of the University of Missouri
    Inventor: Peter Koulen
  • Publication number: 20180017979
    Abstract: Methods and products are provided for facilitating application of variable-product agrochemicals, such as fertilizer, to an application area, such as a field. The fertilizer or agrochemical may include a single fertilizer or agrochemical type or a mixture. In one embodiment, a fertilizer-application area is divided into application cells, and a fertilizer product is determined for each cell, based on zones of the application area with a similar characteristic, such as topographic wetness index levels. Based on a determined product for each cell, instructions for controlling an agrochemical applicator are automatically generated.
    Type: Application
    Filed: November 5, 2013
    Publication date: January 18, 2018
    Applicant: The Curators of the University of Missouri
    Inventors: Peter P. Motavalli, Kelly A. Nelson
  • Publication number: 20180019495
    Abstract: An energy storage system reaction cell configured for distribution throughout a transport system. The length of the reaction cell is substantially greater than its width and is looped throughout the transport system in a serpentine configuration. A membrane within the reaction cell has a length substantially equal to the length of the reaction cell such that surface area of the membrane is maximized relative to volume of the reaction cell to increase electrical power provided to an electrical load of the transport system.
    Type: Application
    Filed: July 14, 2016
    Publication date: January 18, 2018
    Applicant: The Curators of the University of Missouri
    Inventors: Jonghyun Park, Mohammed Al-Yasiri
  • Patent number: 9861958
    Abstract: Embodiments relate to a cerium-containing nano-coating composition, the composition including an amorphous matrix including one or more of cerium oxide, cerium hydroxide, and cerium phosphate; and crystalline regions including one or more of crystalline cerium oxide, crystalline cerium hydroxide, and crystalline cerium phosphate. The diameter of each crystalline region is less than about 50 nanometers.
    Type: Grant
    Filed: June 17, 2014
    Date of Patent: January 9, 2018
    Assignee: The Curators of The University of Missouri
    Inventors: Matthew J. O'Keefe, Carlos E. Castano Londono, William G. Fahrenholtz
  • Patent number: 9862697
    Abstract: The invention is directed to dual-analyte fluorescent chemosensors for the direct detection and visualization (imaging) of neurotransmitters released upon exocytosis. The inventive sensor exploits the high concentration of neurotransmitters (e.g., glutamate, norepinephrine, and dopamine) and capitalizes upon the pH gradient between the vesicle and synaptic cleft.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: January 9, 2018
    Assignee: The Curators of the University of Missouri
    Inventors: Timothy E Glass, Kevin D Gillis, Kenneth S Hettie, Jessica L Klockow
  • Patent number: 9849101
    Abstract: A method for enhancing amidohydrolase activity of Fatty Acid Amide Hydrolase (FAAH) is disclosed. The method comprising administering a phenoxyacyl-ethanolamide that causes the enhanced activity. The enhanced activity can have numerous effects on biological organisms including, for example, enhancing the growth of certain seedlings.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: December 26, 2017
    Assignees: Research Foundation of the City University of New York, The Curators of the University of Missouri, University of North Texas
    Inventors: George John, Subbiah Nagarajan, Kent Chapman, Lionel Faure, Peter Koulen
  • Patent number: 9830422
    Abstract: Systems, methods and computer-readable media are described herein for determining a protein's most-likely structural alignment. A maximum likelihood algorithm is utilized that compares possible input protein structural translocations with a template protein. It then calculates the optimally superimposed position for each input protein utilizing a distance-based probability scoring algorithm that accurately manages extreme distances.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: November 28, 2017
    Assignee: The Curators of the University of Missouri
    Inventors: Gerald Wyckoff, Scott Foy
  • Patent number: 9820475
    Abstract: The disclosure relates to genetically modified swine wherein at least one allele of a SIGLEC1 gene has been inactivated and/or at least one allele of a CD163 gene has been inactivated. Genetically modified swine having both alleles of the SIGLEC1 gene and/or both alleles CD 163 gene inactivated are resistant to porcine reproductive and respiratory syndrome virus (PRRSV). Methods for producing such transgenic swine are also provided.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: November 21, 2017
    Assignee: The Curators of the University of Missouri
    Inventors: Randall S. Prather, Kevin D. Wells, Kristin M. Whitworth
  • Patent number: 9814719
    Abstract: The present disclosure relates to chemical compounds, methods for their discovery, and their therapeutic and research use. In particular, the present disclosure provides compounds as therapeutic agents against bacterial infections (e.g., biofilms). The present disclosure also provides compounds as therapeutic agents in methods for treating pneumonia, methods for reducing bacterial virulence, methods for treating a bacterial wound infection, and methods for treating a urinary tract infection. The present disclosure also provides methods for treating a bacterial infection, wherein the bacterial infection has or is suspected of having an antibiotic-resistant bacteria. The present disclosure also provides surfaces coated with the chemical compounds disclosed herein.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: November 14, 2017
    Assignee: Curators of the University of Missouri
    Inventors: Hongmin Sun, David W. Anderson, Lianhai Li
  • Patent number: 9805928
    Abstract: The present invention provides a method to manufacture nanowires. In various embodiments, a method is provided for producing an oxidized metal layer as a heterogeneous seed layer on arbitrary substrate for controlled nanowire growth is disclosed which comprises depositing a metal layer on a substrate, oxidizing the metal layer in air ambient or in oxidizing agent, and growing nanowires at low temperatures on oxidized metal layers on virtually any substrate.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: October 31, 2017
    Assignee: The Curators of the University of Missouri
    Inventors: Jae Wan Kwon, Baek Hyun Kim
  • Publication number: 20170300686
    Abstract: Method, system and media for authenticating a subject as a user. Embodiments generate visual stories specific to the user and for which the subject must select the corresponding images from among a plurality of decoy images. Gaze tracking can be used to determine which images the user has selected without allowing an observer to learn which images have been selected. Images for the visual story can be retrieved from the user's social networking profile, and corresponding text storied generated to indicate which images should be selected. Multiple security levels are possible by varying the number of story images and decoy images.
    Type: Application
    Filed: October 16, 2015
    Publication date: October 19, 2017
    Applicant: The Curators of the University of Missouri
    Inventors: Chi-Ren SHYU, Hongfei CAO, Matthew KLARIC, Jeffrey UHLMANN
  • Patent number: 9783779
    Abstract: The present invention provides novel methods for improving the efficiency of artificial activation of unfertilized mammalian oocytes by reducing the intracellular concentration of Zn2+ in the oocyte. The methods of the invention may additionally comprise a preceding step of increasing the intracellular concentration of Ca2+ in the oocyte prior to reduction of the intracellular Zn2+ concentration. The invention further provides unfertilized oocytes activated by the disclosed methods and viable mammalian animals produced from unfertilized oocytes activated by the disclosed methods.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: October 10, 2017
    Assignee: The Curators of the University of Missouri
    Inventors: Kiho Lee, Randall S. Prather
  • Patent number: 9766252
    Abstract: An embodiment of the invention is a peptide comprising four domains, wherein domain I consists of thioctyl or monocytl, domain II consists of 2 to 3 positively charged amino acids selected from the group consisting of lysine and arginine, domain III consists of a dimeric ethylene unit; and domain IV comprises the peptide with SEQ ID No. 1 or a sequence having at least 90% identity to SEQ ID No. I. The peptide is preferably attached to a gold nanostructure, preferably a gold nanorod to provide an EFGR kit. An EFGR detection kit of the invention employs a gold nanostructure attached to a peptide sequence, the peptide sequence includes a binding sequence with an affinity toward EGFR, a ligand bound to gold atoms of the nanorod, a positively charged amino acid that maintains activity of the binding sequence, and a unit that increases hydrophilicity of the peptide sequence.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: September 19, 2017
    Assignee: The Curators of the University of Missouri
    Inventors: Raghuraman Kannan, Gerald Arthur, Charles W. Caldwell, Jr., Charles Caldwell, Mripen Chanda, Ajit Zambre, Mythili Ramachandran
  • Publication number: 20170258495
    Abstract: The present invention provides a novel oocyte maturation medium or/and embryo culture medium with a chemically defined supplement to produce matured oocytes at high efficiency. The inventive medium or supplement comprises three growth factors, namely, fibroblast growth factor 2 (FGF2), leukemia inhibitory factor (LIF), and insulin-like growth factor 1 (IGF-1) in a synergistic combination. Methods for oocyte and embryo culture are also provided.
    Type: Application
    Filed: February 28, 2017
    Publication date: September 14, 2017
    Applicant: The Curators of the University of Missouri
    Inventors: Ye Yuan, Lee D. Spate, Randall S. Prather, R. Michael Roberts
  • Patent number: 9752116
    Abstract: A composition comprising a plurality of cell aggregates for use in the production of engineered organotypic tissue by organ printing. A method of making a plurality of cell aggregates comprises centrifuging a cell suspension to form a pellet, extruding the pellet through an orifice, and cutting the extruded pellet into pieces. Apparatus for making cell aggregates comprises an extrusion system and a cutting system. In a method of organ printing, a plurality of cell aggregates are embedded in a polymeric or gel matrix and allowed to fuse to form a desired three-dimensional tissue structure. An intermediate product comprises at least one layer of matrix and a plurality of cell aggregates embedded therein in a predetermined pattern. Modeling methods predict the structural evolution of fusing cell aggregates for combinations of cell type, matrix, and embedding patterns to enable selection of organ printing processes parameters for use in producing an engineered tissue having a desired three-dimensional structure.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: September 5, 2017
    Assignees: The Curators of the University of Missouri, MUSC Foundation for Research Development
    Inventors: Gabor Forgacs, Karoly Jakab, Adrian Neagu, Vladimir Mironov